The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment duration with avutometinib/defactinib in recurrent low-grade serous ovarian carcinoma by KRAS mutation status.
 
Anna Shvygin
No Relationships to Disclose
 
Qin Zhou
Other Relationship - Morgan and Morgan Complex Litigation Group
 
Carol Aghajanian
Leadership - GOG Foundation; NRG Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; WCG
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Dennis Chi
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - BioNTech SE; Doximity
Honoraria - AstraZeneca
Consulting or Advisory Role - Biom'up; Verthermia
 
Alexia Iasonos
Stock and Other Ownership Interests - Bristol-Myers Squibb/Sanofi
Consulting or Advisory Role - Bristol Myers Squibb; Intelligencia
 
Roisin O'Cearbhaill
Honoraria - Aptitude Health; Cardinal Health; Curio Science; GlaxoSmithKline; GOG Foundation; MJH/PER
Consulting or Advisory Role - GlaxoSmithKline; GOG Foundation; Immunogen; Loxo/Lilly; Regeneron; Seagan; Takeda Science Foundation
Research Funding - Acrivon Therapeutics (Inst); ArsenalBio (Inst); AstraZeneca/Merck (Inst); Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Context Therapeutics (Inst); Debiopharm Group (Inst); Genentech (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Iovance Biotherapeutics (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Ludwig Institute for Cancer Research (Inst); Lyell Immunopharma (Inst); Merck/Genentech (Inst); Mural Oncology (Inst); OnCusp Therapeutics (Inst); Regeneron (Inst); Sellas Life Sciences (Inst); Syndax (Inst); TapImmune Inc. (Inst); TCR2 Therapeutics (Inst)
Travel, Accommodations, Expenses - Gathering Around Cancer; Society of Gynecologic Oncology
Other Relationship - JAMA Oncology
 
Aaron Praiss
No Relationships to Disclose
 
Britta Weigelt
Employment - AstraZeneca (I)
Stock and Other Ownership Interests - Repare Therapeutics (I)
Research Funding - Repare Therapeutics (Inst); SAGA Diagnostics (Inst)
 
Rachel Grisham
Employment - Memorial Sloan-Kettering Cancer Center
Consulting or Advisory Role - AstraZeneca; Corcept Therapeutics; GlaxoSmithKline; Intellisphere; Signatera; SpringWorks Therapeutics; Verastem
Research Funding - Bayer (Inst); Context Therapeutics (Inst); Novartis (Inst); SpringWorks Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - EMD Serono
Other Relationship - Aptitude Health; Cardinal Health; MCM Education; OncLive; Prime Oncology
(OPTIONAL) Uncompensated Relationships - Verastem